These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 20099669)
1. [Management of malaria in Benin: evaluation of the practices of healthcare professionals following the introduction of artemisinin derivatives]. Ogouyemi-Hounto A; Kinde-Gazard D; Nahum A; Abdillahi A; Massougbodji A Med Trop (Mars); 2009 Dec; 69(6):561-4. PubMed ID: 20099669 [TBL] [Abstract][Full Text] [Related]
2. [A randomized clinical trial comparing the effectiveness and tolerability of artemisinine-naphthoquine (Arco®) and artemether-lumefantrine (Coartem®) in the treatment of uncomplicated malaria in Benin]. Kinde-Gazard D; Ogouyèmi-Hounto A; Capo-Chichi L; Gbaguidi J; Massougbodji A Bull Soc Pathol Exot; 2012 Aug; 105(3):208-14. PubMed ID: 22328063 [TBL] [Abstract][Full Text] [Related]
3. [Practices of caregivers and national recommendations for treatment of malaria in Benin in 2009]. Robin S; Bruneton C; Guévart E Bull Soc Pathol Exot; 2017 Aug; 110(3):207-216. PubMed ID: 28144847 [TBL] [Abstract][Full Text] [Related]
4. Prescription practices and availability of artemisinin monotherapy in India: where do we stand? Mishra N; Anvikar AR; Shah NK; Kamal VK; Sharma SK; Srivastava HC; Das MK; Pradhan K; Kumar H; Gupta YK; Gupta P; Dash AP; Valecha N Malar J; 2011 Dec; 10():360. PubMed ID: 22166073 [TBL] [Abstract][Full Text] [Related]
5. Health workers perceptions on chloroquine and sulfadoxine/sulfalene pyrimethamine monotherapies: implications for the change to combination therapy of artemether/lumefantrine in Tanzania. Tarimo DS; Malekela DA East Afr J Public Health; 2007 Apr; 4(1):43-6. PubMed ID: 17907761 [TBL] [Abstract][Full Text] [Related]
6. Trends in malaria case management following changes in the treatment policy to artemisinin combination therapy at the Mbakong Health Centre, Cameroon 2006-2012: a retrospective study. Ndong IC; Reenen Mv; Boakye DA; Mbacham WF; Grobler AF Acta Trop; 2015 Oct; 150():100-6. PubMed ID: 26095044 [TBL] [Abstract][Full Text] [Related]
7. Insights following change in drug policy: a descriptive study for antimalarial prescription practices in children of public sector health facilities in Jharkhand state of India. Mishra N; Gupta R; Singh S; Rana R; Shahi B; Das MK; Anvikar AR; Valecha N J Vector Borne Dis; 2013 Dec; 50(4):271-7. PubMed ID: 24499849 [TBL] [Abstract][Full Text] [Related]
8. Updated CDC Recommendations for Using Artemether-Lumefantrine for the Treatment of Uncomplicated Malaria in Pregnant Women in the United States. Ballard SB; Salinger A; ; Arguin PM; Desai M; Tan KR MMWR Morb Mortal Wkly Rep; 2018 Apr; 67(14):424-431. PubMed ID: 29649190 [TBL] [Abstract][Full Text] [Related]
10. A randomized clinical trial comparing safety, clinical and parasitological response to artemether-lumefantrine and chlorproguanil-dapsone in treatment of uncomplicated malaria in pregnancy in Mulago hospital, Uganda. Kaye DK; Nshemerirwe R; Mutyaba TS; Ndeezi G J Infect Dev Ctries; 2008 Apr; 2(2):135-9. PubMed ID: 19738339 [TBL] [Abstract][Full Text] [Related]
11. Anti-malarial prescribing practices in Sudan eight years after introduction of artemisinin-based combination therapies and implications for development of drug resistance. Elmannan AA; Elmardi KA; Idris YA; Spector JM; Ali NA; Malik EM BMC Pharmacol Toxicol; 2015 Mar; 16():3. PubMed ID: 25889116 [TBL] [Abstract][Full Text] [Related]
12. The malaria testing and treatment landscape in Benin. ; Zinsou C; Cherifath AB Malar J; 2017 Apr; 16(1):174. PubMed ID: 28446236 [TBL] [Abstract][Full Text] [Related]
13. Does the consent of the patients have a role to play in formulating a treatment policy? Kango M; Baboo KS Trop Doct; 2008 Jan; 38(1):56-7. PubMed ID: 18302874 [TBL] [Abstract][Full Text] [Related]
14. Low use of artemisinin-based combination therapy for febrile children under five and barriers to correct fever management in Benin: a decade after WHO recommendation. Damien BG; Aguemon B; Abdoulaye Alfa D; Bocossa D; Ogouyemi-Hounto A; Remoue F; Le Hesran JY BMC Public Health; 2018 Jan; 18(1):168. PubMed ID: 29357869 [TBL] [Abstract][Full Text] [Related]
15. Access to artemisinin-based combination therapy (ACT) and quinine in malaria holoendemic regions of western Kenya. Watsierah CA; Ouma C Malar J; 2014 Jul; 13():290. PubMed ID: 25066600 [TBL] [Abstract][Full Text] [Related]
16. [Evaluation of the quality of prescription and dispensing of artemisinin-based therapeutic combinations in the Bamako District, Mali]. Eve S; Samba D; Benoît D; Diawara SI; Seidina D; Saibou D; Karim T; Drissa K; Seydou D; Fanta Mady TS; Mahamadou D Mali Med; 2010; 25(3):31-40. PubMed ID: 21441091 [TBL] [Abstract][Full Text] [Related]
17. Antimalarial drug prescribing practice in private and public health facilities in South-east Nigeria: a descriptive study. Meremikwu M; Okomo U; Nwachukwu C; Oyo-Ita A; Eke-Njoku J; Okebe J; Oyo-Ita E; Garner P Malar J; 2007 May; 6():55. PubMed ID: 17480216 [TBL] [Abstract][Full Text] [Related]
18. Adding artesunate to sulphadoxine-pyrimethamine greatly improves the treatment efficacy in children with uncomplicated falciparum malaria on the coast of Benin, West Africa. Nahum A; Erhart A; Gazard D; Agbowai C; Van Overmeir C; van Loen H; Menten J; Akogbeto M; Coosemans M; Massougbodji A; D'Alessandro U Malar J; 2007 Dec; 6():170. PubMed ID: 18154655 [TBL] [Abstract][Full Text] [Related]
19. Awareness of anti-malarial policy and malaria treatment practices of patent medicine vendors in three Nigerian states. Oladepo O; Brieger W; Adeoye B; Lawal B; Peters DH Afr J Med Med Sci; 2011 Dec; 40(4):345-52. PubMed ID: 22783684 [TBL] [Abstract][Full Text] [Related]
20. Impact of delayed introduction of sulfadoxine-pyrimethamine and arthemeter-lumefantrine on malaria epidemiology in KwaZulu-Natal, South Africa. Knight SE; Anyachebelu EJ; Geddes R; Maharaj R Trop Med Int Health; 2009 Sep; 14(9):1086-92. PubMed ID: 19624481 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]